ELECTRIC FIELDS ON METABOLISM OF A CHRONIC WOUND MODEL
Project Number1K08HD001065-01
Contact PI/Project LeaderGOLDMAN, ROBERT J
Awardee OrganizationUNIVERSITY OF PENNSYLVANIA
Description
Abstract Text
Among the patients treated by Rehabilitation Medicine are those with
decubitus and leg ulcers. These have significant morbidity, mortality
and often are resistant to conventional treatment. The efficacy of
electrotherapy is unsettled after decades of use and the possibility
remains that a natural source of electricity within wounds(i.e., the
"skin battery") may promote healing.
We propose to elaborate the observation that fibroblasts decrease protein
synthesis if exposed to electric fields comparable to endogenous fields.
For this purpose, human dermal fibroblasts in type I collagen dermal
"equivalent" matrices (DEM) are exposed to ionic currents. Initial
results from our DEM model are promising. They suggests an increase in
proliferation to electric fields of 20 mv/m, 10Hz.(p,01). (Most often
synthesis and proliferation are reciprocal).
Employing the same model, we propose a comprehensive study of the
biochemical response of the DEM model to these electric fields. We plan
radioisotope assays for DNA, proteoglycans, collagen, fibronectin and
collagenase. Identifying the process most susceptible to electric
effect, we will survey response to amplitudes and frequencies within the
endogenous range. If the skin battery is important to wound healing,
cells should be most sensitive at 1-10 Hz (i.e., down to 5-20 m/m).
Early after wounding, fibroblasts undergo fibroplasia, and synthesis of
proteoglycans and fibronectin. Later, collagen synthesis and
neoangiogenisis peak. We will investigate the biochemical response of
fibroblasts in DEM from 0 to 14 days after stimulation to see if these
biosynthetic transformations occur in vitro. If they do, we will have
compelling evidence that the skin battery help mediates the response in
vivo. Lastly, we will investigate electric effects on early
intracellular events that ultimately lead to proliferation and/or
synthesis.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
042250712
UEI
GM1XX56LEP58
Project Start Date
01-July-1994
Project End Date
30-June-1999
Budget Start Date
01-July-1994
Budget End Date
30-June-1995
Project Funding Information for 1994
Total Funding
$82,080
Direct Costs
$76,000
Indirect Costs
$6,080
Year
Funding IC
FY Total Cost by IC
1994
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$82,080
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K08HD001065-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K08HD001065-01
Patents
No Patents information available for 1K08HD001065-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K08HD001065-01
Clinical Studies
No Clinical Studies information available for 1K08HD001065-01
News and More
Related News Releases
No news release information available for 1K08HD001065-01
History
No Historical information available for 1K08HD001065-01
Similar Projects
No Similar Projects information available for 1K08HD001065-01